Ghrelin Infusion in Humans Induces Acute Insulin Resistance and Lipolysis Independent of Growth Hormone Signaling
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index; none of the 34 sources its claims cite is checked for support yet.
Abstract
OBJECTIVE—Ghrelin is a gut-derived peptide and an endogenous ligand for the growth hormone (GH) secretagogue receptor. Exogenous ghrelin stimulates the release of GH (potently) and adrenocorticotropic hormone (ACTH) (moderately). Ghrelin is also orexigenic, but its impact on substrate metabolism is controversial. We aimed to study direct effects of ghrelin on substrate metabolism and insulin sensitivity in human subjects. RESEARCH DESIGN AND METHODS—Six healthy men underwent ghrelin (5 pmol · kg−1 · min−1) and saline infusions in a double-blind, cross-over study to study GH signaling proteins in muscle. To circumvent effects of endogenous GH and ACTH, we performed a similar study in eight hypopituitary adults but replaced with GH and hydrocortisone. The methods included a hyperinsulinemic-euglycemic clamp, muscle biopsies, microdialysis, and indirect calorimetry. RESULTS—In healthy subjects, ghrelin-induced GH secretion translated into acute GH receptor signaling in muscle. In the absence of GH and cortisol secretion, ghrelin acutely decreased peripheral, but not hepatic, insulin sensitivity together with stimulation of lipolysis. These effects occurred without detectable suppression of AMP-activated protein kinase phosphorylation (an alleged second messenger for ghrelin) in skeletal muscle. CONCLUSIONS—Ghrelin infusion acutely induces lipolysis and insulin resistance independently of GH and cortisol. We hypothesize that the metabolic effects of ghrelin provide a means to partition glucose to glucose-dependent tissues during conditions of energy shortage.
Overview
CoChat Summary
## TL;DR
This study found that ghrelin infusion in humans acutely increased lipolysis and reduced insulin-stimulated glucose disposal, even when GH and cortisol effects were controlled for in hypopituitary men. In healthy men, ghrelin also triggered endogenous GH release that led to STAT5 phosphorylation in skeletal muscle.
## Key findings
- In 6 healthy men, ghrelin infusion (5 pmol·kg⁻¹·min⁻¹) caused GH to peak at 60 min: 33.3 ± 8.0 μg/l vs. 1.1 ± 0.9 μg/l with saline (P = 0.008), and increased serum FFAs: 1.0 ± 0.1 μg/l vs. 0.4 ± 0.04 μg/l (P = 0.003).
- In those healthy subjects, skeletal muscle biopsies showed distinct STAT5 phosphorylation in all 6 subjects 30 min after the GH burst.
- In 8 hypopituitary men, ghrelin caused an 80% increase in FFAs to 0.62 ± 0.03 mmol/l at 120 min (P < 0.05) and raised plasma glucose to 6.1 ± 0.2 mmol/l at 120 min (P = 0.009).
- During the hyperinsulinemic-euglycemic clamp, ghrelin significantly decreased glucose infusion rate (GIR) (P < 0.01) and reduced the M value by ~60% (P < 0.001); it also reduced oxidative, nonoxidative, and total glucose disposal.
## Methods
- Two human infusion studies were conducted under ethics/GCP approval and registered as NCT00116025 and NCT00139945.
- Study 1: 6 healthy men (age 23 ± 1 years, BMI 23.5 ± 0.4 kg/m²) received saline or ghrelin infusion; a muscle biopsy was taken at 90 min.
- Study 2: 8 hypopituitary men (age 53 ± 4 years, BMI 31.6 ± 1.0 kg/m²) on stable GH and hydrocortisone replacement underwent a randomized double-blind cross-over design with 5-h saline or ghrelin infusions, followed by a hyperinsulinemic-euglycemic clamp from 120 to 300 min; outcomes included tracer-derived glucose kinetics, indirect calorimetry, microdialysis, hormone/metabolite assays, and skeletal muscle signaling by Western blot and PI3K assay.
## Limitations
- The paper states that in Study 2, muscle biopsies were obtained only in the basal period, which limits assessment of aberrations in insulin signaling pathways.
- The authors note that infusion of ghrelin does not imitate the secretory pattern of endogenous ghrelin.
- They also say the study was powered to detect effects on insulin sensitivity, so the lack of significant effects on lipid metabolism may be due to a β error.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
0 Valid · 0 Not valid · 18 Not checked · 44 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Plasma levels of norepinephrine and epinephrine were comparable on both study days”
plainn = 7- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Energy expenditure, RQ, or lipid oxidation were not significantly affected by ghrelin in the basal or in the clamp period.”
plainn = 7- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The increase in RQ (RQ clamp − RQ basal ) during the clamp, however, was larger in the saline study (0.07 ± 0.01 vs. 0.03 ± 0.01 [ghrelin], P = 0.03).”
plainn = 7 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Western blots performed on skeletal muscle biopsies revealed distinct STAT5 phosphorylation in all six subjects 30 min after the endogenous GH burst ( Fig. 3 ).”
plainstates a causen = 6- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A significant elevation in serum FFA levels was recorded (0.4 ± 0.04 μg/l [saline] vs. 1.0 ± 0.1 μg/l [ghrelin]; P = 0.003).”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
22 more claims
Create a free account to see all 62 claims and to verify the 34 references still open.
- Probably not a substantial claim. 29
- The quote only partly states this claim. 6
- It may state two separate claims as one. 10
Citations
Cites
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
Ghrelin enhances appetite and increases food intake in humans
Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., Dhillo, W. S., Ghatei, M. A., & Bloom, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8111 · Cited by 2,494 · cited 1×
“Ghrelin, an endogenous ligand for the growth hormone (GH) secretagogue receptor (GHS-R), stimulates GH and adrenocorticotropic hormone (ACTH) secretion (1) in addition to having orexigenic and gastrokinetic effects (2,3).”
BackgroundDeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., & Felber, J. P. (1981) · Diabetes · doi:10.2337/diab.30.12.1000 · Cited by 1,770
INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT*
Steele, R. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb44923.x · Cited by 1,670
The theoretical bases of indirect calorimetry: A review
Ferrannini, E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90110-2 · Cited by 1,580
THE AMP-ACTIVATED/SNF1 PROTEIN KINASE SUBFAMILY: Metabolic Sensors of the Eukaryotic Cell?
Hardie, D. G., Carling, D., & Carlson, M. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.821 · Cited by 1,435
Ghrelin Strongly Stimulates Growth Hormone Release in Humans
Takaya, K., Ariyasu, H., Kanamoto, N., Iwakura, H., Yoshimoto, A., Harada, M., Mori, K., Komatsu, Y., Usui, T., Shimatsu, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7167 · Cited by 864 · cited 1×
“Ghrelin, an endogenous ligand for the growth hormone (GH) secretagogue receptor (GHS-R), stimulates GH and adrenocorticotropic hormone (ACTH) secretion (1) in addition to having orexigenic and gastrokinetic effects (2,3).”
BackgroundAMP-activated Protein Kinase Plays a Role in the Control of Food Intake
Andersson, U., Filipsson, K., Abbott, C. R., Woods, A., Smith, K., Bloom, S. R., Carling, D., & Small, C. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300557200 · Cited by 755
Kola, B., Hubina, E., Tucci, S. A., Kirkham, T. C., Garcia, E. A., Mitchell, S. E., Williams, L. M., Hawley, S. A., Hardie, D. G., Grossman, A. B., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500175200 · Cited by 472
Growth Hormone Secretagogue Binding Sites in Peripheral Human Tissues1
Papotti, M., Ghè, C., Cassoni, P., Catapano, F., Deghenghi, R., Ghigo, E., & Muccioli, G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6846 · Cited by 410
Cited by
Regulation of adipocyte lipolysis
Frühbeck, G., Méndez-Giménez, L., Fernández-Formoso, J.-A., Fernández, S., & Rodríguez, A. (2014) · Nutrition Research Reviews · doi:10.1017/s095442241400002x · Cited by 429
Tong, J., Prigeon, R. L., Davis, H. W., Bidlingmaier, M., Kahn, S. E., Cummings, D. E., Tschöp, M. H., & D'Alessio, D. (2010) · Diabetes · doi:10.2337/db10-0504 · Cited by 333
Isbell, J. M., Tamboli, R. A., Hansen, E. N., Saliba, J., Dunn, J. P., Phillips, S. E., Marks-Shulman, P. A., & Abumrad, N. N. (2010) · Diabetes Care · doi:10.2337/dc09-2107 · Cited by 248
Dimitriadis, G. D., Maratou, E., Kountouri, A., Board, M., & Lambadiari, V. (2021) · Nutrients · doi:10.3390/nu13010159 · Cited by 241
“Continuous infusions of acylated ghrelin in healthy subjects and hypopituitary patients for 300 min acutely induced insulin resistance, increased lipolysis, and serum NEFA levels and suppressed insulin-stimulated glucose disposal [231].”
BackgroundMethodGut-Derived Serotonin Is a Multifunctional Determinant to Fasting Adaptation
Sumara, G., Sumara, O., Kim, J. K., & Karsenty, G. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.014 · Cited by 224
Ferrannini, E., & Mingrone, G. (2009) · Diabetes Care · doi:10.2337/dc08-1762 · Cited by 194
Intestinal Cholecystokinin Controls Glucose Production through a Neuronal Network
Cheung, G. W. C., Kokorovic, A., Lam, C. K. L., Chari, M., & Lam, T. K. T. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.07.005 · Cited by 182
Ghrelin – Physiological Functions and Regulation
Ibrahim Abdalla, M. M., & Senior Lecturer, P. D. (2015) · European Endocrinology · doi:10.17925/ee.2015.11.02.90 · Cited by 130
Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment
Ashby, D. R., Ford, H. E., Wynne, K., Wren, A., Murphy, K. G., Busbridge, M., Brown, E. A., Taube, D. H., Ghatei, M. A., Tam, F. W. K., et al. (2009) · Kidney International · doi:10.1038/ki.2009.114 · Cited by 136
Gruzman, A., Babai, G., & Sasson, S. (2009) · The Review of Diabetic Studies · doi:10.1900/rds.2009.6.13 · Cited by 128
Physiological Effect of Ghrelin on Body Systems
Akalu, Y., Molla, M. D., Dessie, G., & Ayelign, B. (2020) · International Journal of Endocrinology · doi:10.1155/2020/1385138 · Cited by 145
Metabolic Status Regulates Ghrelin Function on Energy Homeostasis
Briggs, D. I., & Andrews, Z. B. (2011) · Neuroendocrinology · doi:10.1159/000322589 · Cited by 123
Ghrelin and glucose homeostasis
Delhanty, P. J. D., & van der Lely, A. J. (2011) · Peptides · doi:10.1016/j.peptides.2011.03.001 · Cited by 136
The Human Experience With Ghrelin Administration
Garin, M. C., Burns, C. M., Kaul, S., & Cappola, A. R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4247 · Cited by 107
Hypothalamic Control of Lipid Metabolism: Focus on Leptin, Ghrelin and Melanocortins
Diéguez, C., Vazquez, M. J., Romero, A., López, M., & Nogueiras, R. (2011) · Neuroendocrinology · doi:10.1159/000328122 · Cited by 105
Ghrelin’s Relationship to Blood Glucose
Mani, B. K., Shankar, K., & Zigman, J. M. (2019) · Endocrinology · doi:10.1210/en.2019-00074 · Cited by 97
Callaghan, B. P., & Furness, J. B. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008433 · Cited by 102
Granata, R., Volante, M., Settanni, F., Gauna, C., Ghé, C., Annunziata, M., Deidda, B., Gesmundo, I., Abribat, T., van der Lely, A.-J., et al. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0141 · Cited by 89
Insulin resistance and bariatric surgery
Rao, R. S., Yanagisawa, R., & Kini, S. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00955.x · Cited by 89
Ghrelin and Cardiovascular Diseases
Zhang, G., Yin, X., Qi, Y., PENDYALA, L. K., Chen, J. C., Hou, D., & Tang, C.-S. (2010) · Current Cardiology Reviews · doi:10.2174/157340310790231662 · Cited by 84
Interrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevance
Chabot, F. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i3.328 · Cited by 84
The Molecular Brakes of Adipose Tissue Lipolysis
Li, Y., Li, Z., Ngandiri, D. A., Perez, M. L., Wolf, A., & Wang, Y. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.826314 · Cited by 101
Ghrelin regulation of glucose metabolism
Gray, S. M., PAGE, L. C., & Tong, J. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12705 · Cited by 85
Bhattacharya, S. K., Andrews, K., Beveridge, R., Cameron, K. O., Chen, C., Dunn, M., Fernando, D., Gao, H., Hepworth, D., Jackson, V. M., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400473x · Cited by 73
GOAT: the master switch for the ghrelin system?
Romero, A., Kirchner, H., Heppner, K. M., Pfluger, P. T., Tschöp, M. H., & Nogueiras, R. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0099 · Cited by 87
The suppression of ghrelin signaling mitigates age-associated thermogenic impairment
Lin, L., Lee, J. H., Bongmba, O. Y. N., Ma, X., Zhu, X., Sheikh-Hamad, D., & Sun, Y. (2014) · Aging · doi:10.18632/aging.100706 · Cited by 67
Heppner, K. M., & Tong, J. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0183 · Cited by 71
Barazzoni, R., Zhu, X., DeBoer, M. D., Datta, R., Culler, M. D., Zanetti, M., Guarnieri, G., & Marks, D. L. (2009) · Kidney International · doi:10.1038/ki.2009.411 · Cited by 69
Cruz, S. A., Tseng, Y., Kaiya, H., & Hwang, P. (2010) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2010.01.019 · Cited by 67
Integrating GHS into the Ghrelin System
Veldhuis, J. D., & Bowers, C. Y. (2010) · International Journal of Peptides · doi:10.1155/2010/879503 · Cited by 67
Denney, W. S., Sonnenberg, G. E., Carvajal‐Gonzalez, S., Tuthill, T., & Jackson, V. M. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13127 · Cited by 57
Gut hormones as therapeutic agents in treatment of diabetes and obesity
Tan, T., & Bloom, S. R. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.09.005 · Cited by 66
Camilleri, M., & Acosta, A. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12490 · Cited by 54
Tong, J., Prigeon, R. L., Davis, H. W., Bidlingmaier, M., Tschöp, M. H., & D'Alessio, D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4162 · Cited by 53
de Paula, A. L., Stival, A. R., Halpern, A., DePaula, C. C. L., Mari, A., Muscelli, E., Vencio, S. A. C., & Ferrannini, E. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1550-6 · Cited by 60
Effect of Ghrelin on Glucose-Insulin Homeostasis: Therapeutic Implications
Sangiao‐Alvarellos, S., & Cordido, F. (2010) · International Journal of Peptides · doi:10.1155/2010/234709 · Cited by 57
Krusenstjerna-Hafstrøm, T., Clasen, B. F., Møller, N., Jessen, N., Pedersen, S. B., Christiansen, J. S., & Jørgensen, J. O. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0273 · Cited by 51
Self-citationThe regulation of gastric ghrelin secretion
Nunez‐Salces, M., Li, H., Feinle‐Bisset, C., Young, R. L., & Page, A. J. (2020) · Acta Physiologica · doi:10.1111/apha.13588 · Cited by 49
The ghrelin O-acyltransferase–ghrelin system: a novel regulator of glucose metabolism
Heppner, K. M., Tong, J., Kirchner, H., Nass, R. M., & Tschöp, M. H. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328341e1d3 · Cited by 47
Tong, J., Davis, H. W., Summer, S., Benoit, S. C., Haque, A., Bidlingmaier, M., Tschöp, M. H., & D’Alessio, D. (2014) · Diabetes · doi:10.2337/db13-1598 · Cited by 48
Granata, R., Settanni, F., Julien, M., Nano, R., Togliatto, G., Trombetta, A., Gallo, D., Piemonti, L., Brizzi, M. F., Abribat, T., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201223m · Cited by 50
Acute Peripheral Metabolic Effects of Intraarterial Ghrelin Infusion in Healthy Young Men
Vestergaard, E. T., Buhl, M. R., Gjedsted, J., Madsen, M. A., Jessen, N., Nielsen, S., Gaylinn, B. D., Liu, J., Thorner, M. O., Møller, N., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1995 · Cited by 43
Self-citationTong, J., Davis, H. W., Gastaldelli, A., & D’Alessio, D. A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4154 · Cited by 46
Barazzoni, R., Semolic, A., Cattin, M. R., Zanetti, M., & Guarnieri, G. (2013) · Obesity · doi:10.1002/oby.20454 · Cited by 47
Straznicky, N. E., Eikelis, N., Nestel, P. J., Dixon, J. B., Dawood, T., Grima, M. T., Sari, C. I., Schlaich, M. P., Esler, M., Tilbrook, A. J., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2320 · Cited by 44
Ghrelin contributes to derangements of glucose metabolism induced by rapamycin in mice
Xu, G., Wang, Z., Li, Y., Li, Z., Tang, H. W., Zhao, J., Xiang, X., Ding, L., Ma, L., Yuan, F., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2509-1 · Cited by 42
Acyl Ghrelin Induces Insulin Resistance Independently of GH, Cortisol, and Free Fatty Acids
Vestergaard, E. T., Jessen, N., Møller, N., & Jørgensen, J. O. L. (2017) · Scientific Reports · doi:10.1038/srep42706 · Cited by 42
Self-citationCapromorelin: a ghrelin receptor agonist and novel therapy for stimulation of appetite in dogs
Rhodes, L., Zollers, B., Wofford, J. A., & Heinen, E. (2017) · Veterinary Medicine and Science · doi:10.1002/vms3.83 · Cited by 49
Small Molecule Ghrelin Receptor Inverse Agonists and Antagonists
Cameron, K. O., Bhattacharya, S. K., & Loomis, A. K. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5003183 · Cited by 40
A Recent Update on the Role of Ghrelin in Glucose Homeostasis
Briggs, D. I., & Andrews, Z. B. (2011) · Current Diabetes Reviews · doi:10.2174/157339911795843140 · Cited by 40
Hinshaw, L., Schiavon, M., Mallad, A., Man, C. D., Basu, R., Bharucha, A. E., Cobelli, C., Carter, R. E., Basu, A., & Kudva, Y. C. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00199.2014 · Cited by 35
Emerging therapies in the treatment of ‘diabesity’: beyond GLP-1
Tharakan, G., Tan, T., & Bloom, S. R. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.10.003 · Cited by 39
Ghrelin and growth hormone: Story in reverse
Nass, R. M., Gaylinn, B. D., Rogol, A. D., & Thorner, M. O. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002941107 · Cited by 34
Kharbanda, K. K., Farokhnia, M., Deschaine, S. L., Bhargava, R., Rodríguez-Flores, M., Casey, C. A., Goldstone, A. P., Jerlhag, E., Leggio, L., & Rasineni, K. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14967 · Cited by 35
Vila, G., Riedl, M., Resl, M., van der Lely, A. J., Hofland, L. J., Clodi, M., & Luger, A. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0227 · Cited by 31
Role of ghrelin in pancreatic development and function
Napolitano, T., Silvano, S., Vieira, A., Balaji, S., Garrido‐Utrilla, A., Friano, M. E., Atlija, J., & Collombat, P. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13385 · Cited by 53
Endocrine and Metabolic Actions of Ghrelin
Gasco, V., Beccuti, G., Marotta, F., Benso, A., Granata, R., Broglio, F., & Ghigo, E. (2010) · Endocrine Development · doi:10.1159/000262531 · Cited by 30
Effect of ghrelin on glucose regulation in mice
Chacko, S. K., Haymond, M. W., Sun, Y., Marini, J. C., Sauer, P. J. J., Ma, X., & Sunehag, A. L. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00445.2011 · Cited by 32
Kong, J., Chuddy, J., Stock, I. A., Loria, P. M., Straub, S. V., Vage, C., Cameron, K. O., Bhattacharya, S. K., Lapham, K., McClure, K. F., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13439 · Cited by 29
Tamboli, R. A., Antoun, J., Sidani, R. M., Clements, A., Harmata, E. E., Marks‐Shulman, P., Gaylinn, B. D., Williams, B., Clements, R. H., Albaugh, V. L., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12952 · Cited by 31
Li, J., Huang, P., Xiong, J., Liang, X., Li, M., Ke, H., Chen, C., Han, Y., Huang, Y., Zhou, Y., et al. (2022) · Endocrine Connections · doi:10.1530/ec-22-0012 · Cited by 33
Somatotropic axis resistance and ghrelin in critically ill foals
Barsnick, R., Hurcombe, S. D. A., Dembek, K. A., Frazer, M., Slovis, N. M., Saville, W. J. A., & Toribio, R. E. (2013) · Equine Veterinary Journal · doi:10.1111/evj.12086 · Cited by 27
Dobutović, B., Sudar-Milovanovic, E. M., Tepavčević, S., Djordjevic, J., Djordjevic, A. D., Radojcic, M. B., & Isenović, E. R. (2014) · Archives of Medical Science · doi:10.5114/aoms.2014.44872 · Cited by 33
Krusenstjerna-Hafstrøm, T., Madsen, M. A., Vendelbo, M. H., Pedersen, S. B., Christiansen, J. S., Møller, N., Jessen, N., & Jørgensen, J. O. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019392 · Cited by 27
Self-citationVestergaard, E. T., Møller, N., & Jørgensen, J. O. L. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00662.2012 · Cited by 27
Self-citationGribble, F. M., Reimann, F., & Roberts, G. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00002-5 · Cited by 30
Serum Acylated Ghrelin Is Negatively Correlated with the Insulin Resistance In the CODING study
Amini, P., Wadden, D., Cahill, F., Randell, E. W., Vasdev, S., Chen, X., Gulliver, W. P., Zhang, W., Zhang, H., Yi, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045657 · Cited by 30
Liraglutide acutely suppresses glucagon, lipolysis and ketogenesis in type 1 diabetes
Garg, M., Ghanim, H., Kuhadiya, N. D., Green, K., HEJNA, J. M., Abuaysheh, S., Torre, B., Batra, M., Makdissi, A., Chaudhuri, A., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12944 · Cited by 26
Ghrelin as a target for gastrointestinal motility disorders
Meerveld, B. G., Kriegsman, M., & Nelson, R. (2011) · Peptides · doi:10.1016/j.peptides.2011.03.014 · Cited by 27
Ghrelin levels could be involved in the improvement of insulin resistance after bariatric surgery
Santiago‐Fernández, C., García‐Serrano, S., Tomé, M., Valdés, S., Ocaña-Wilhelmi, L., Rodríguez‐Cañete, A., Tinahones, F. J., García‐Fuentes, E., & Garrido‐Sánchez, L. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.05.002 · Cited by 26
Insulin sensitivity and secretion modifications after bariatric surgery.
Castagneto‐Gissey, L., & Mingrone, G. (2012) · PubMed · doi:10.3275/8470 · Cited by 29
A Review of the Cardiovascular and Anti-Atherogenic Effects of Ghrelin
Rizzo, M., Rizvi, A. A., Sudar-Milovanovic, E. M., Šoškić, S., Obradovic, M. M., Montalto, G., Boutjdir, M., Mikhailidis, D. P., & Isenović, E. R. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319270018 · Cited by 29
The Prokinetic Face of Ghrelin
Sallam, H. S., & Chen, J. D. Z. (2010) · International Journal of Peptides · doi:10.1155/2010/493614 · Cited by 26
Sangiao‐Alvarellos, S., Helmling, S., Vazquez, M. J., Klußmann, S., & Cordido, F. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.01.010 · Cited by 28
Endocrinology of the Equine Neonate Energy Metabolism in Health and Critical Illness
Barsnick, R., & Toribio, R. E. (2011) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2010.12.001 · Cited by 27
Clasen, B. F., Krusenstjerna-Hafstrøm, T., Vendelbo, M. H., Thorsen, K., Escande, C., Møller, N., Pedersen, S. B., Jørgensen, J. O. L., & Jessen, N. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p034520 · Cited by 23
Self-citationDifferent ghrelin localisation in adult human and rat endocrine pancreas
Raghay, K., Gallego, R., Scoazec, J., García‐Caballero, T., & Morel, G. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1593-y · Cited by 28
Kolodziejski, P. A., Pruszyńska‐Oszmałek, E., Strowski, M. Z., & Nowak, K. W. (2017) · Endocrine · doi:10.1007/s12020-017-1309-2 · Cited by 24
Tagliamonte, S., Lumaga, R. B., Filippis, F. D., Valentino, V., Ferracane, R., Guerville, M., Gandolfi, I., Barbara, G., Ercolini, D., & Vitaglione, P. (2023) · Food Research International · doi:10.1016/j.foodres.2023.112953 · Cited by 21
Cervone, D. T., Lovell, A. J., & Dyck, D. J. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.04.005 · Cited by 21
Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases
Mosa, R., Zhang, Z., Shao, R., Deng, C., Chen, J., & Chen, C. (2015) · Endocrine · doi:10.1007/s12020-015-0531-z · Cited by 20
Cervone, D. T., & Dyck, D. J. (2017) · Physiological Reports · doi:10.14814/phy2.13320 · Cited by 22
Kouno, T., Akiyama, N., Fujieda, K., Nanchi, I., Okuda, T., Iwasaki, T., Oka, S., & Yukioka, H. (2016) · Peptides · doi:10.1016/j.peptides.2016.11.003 · Cited by 19
Ghrelin signaling in heart remodeling of adult obese mice
Miranda, G. L., Soares, V. M., Vieira, A. K. G., Lessa, J. G., Rodrigues-Cunha, A. C. D. S., Cortez, E. A. C., Garcia‐Souza, É. P., & Moura, A. S. (2012) · Peptides · doi:10.1016/j.peptides.2012.02.025 · Cited by 18
Neuroendocrine and metabolic activities of ghrelin gene products
Baragli, A., Lanfranco, F., Allasia, S., Granata, R., & Ghigo, E. (2011) · Peptides · doi:10.1016/j.peptides.2011.10.024 · Cited by 20
Ghrelin and its analogues as therapeutic agents for anorexia and cachexia in end-stage renal disease
Cheung, W. W., & MAK, R. H. K. (2009) · Kidney International · doi:10.1038/ki.2009.74 · Cited by 18
Interactions of Gastrointestinal Peptides: Ghrelin and Its Anorexigenic Antagonists
Wisser, A.-S., Habbel, P., Wiedenmann, B., Klapp, B. F., Mönnikes, H., & Kobelt, P. (2010) · International Journal of Peptides · doi:10.1155/2010/817457 · Cited by 22
Role of SST, CORT and ghrelin and its receptors at the endocrine pancreas
Chanclón, B., Martínez‐Fuentes, A. J., & Gracia‐Navarro, F. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00114 · Cited by 19
Therapeutic potential of ghrelin treatment for unloading-induced muscle atrophy in mice
Koshinaka, K., Toshinai, K., Mohammad, A., Noma, K., Oshikawa, M., Ueno, H., Yamaguchi, H., & Nakazato, M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.086 · Cited by 16
Huda, M. S. B., Dovey, T. M., Wong, S., English, P., Halford, J. C. G., McCulloch, P. G., Cleator, J., Martin, B., Cashen, J., Hayden, K., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1122 · Cited by 16
Clasen, B. F., Poulsen, M. M., Escande, C., Pedersen, S. B., Møller, N., Chini, E. N., Jessen, N., & Jørgensen, J. O. L. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2215 · Cited by 16
Self-citationProducts of the Ghrelin Gene, the Pancreatic β-Cell and the Adipocyte
Granata, R., & Ghigo, E. (2013) · Endocrine development · doi:10.1159/000346306 · Cited by 20
Hucik, B., Lovell, A. J., Hoecht, E. M., Cervone, D. T., Mutch, D. M., & Dyck, D. J. (2021) · Adipocyte · doi:10.1080/21623945.2021.1945787 · Cited by 14
Ouyang, X., Li, S., Tan, Y., Lin, L., Yin, J., & Chen, J. D. Z. (2019) · Nutrition and Diabetes · doi:10.1038/s41387-019-0072-2 · Cited by 14
Cervone, D. T., Hucik, B., Lovell, A. J., & Dyck, D. J. (2020) · Metabolism Open · doi:10.1016/j.metop.2020.100026 · Cited by 14
Cervone, D. T., Sheremeta, J., Kraft, E. N., & Dyck, D. J. (2018) · Adipocyte · doi:10.1080/21623945.2018.1528811 · Cited by 14
Karschin, J., Lagerpusch, M., Enderle, J., Eggeling, B., Müller, M. J., & Bosy‐Westphal, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117865 · Cited by 14
Shah, M. A., Haris, M. N., Faheem, H. I., Hamid, A., Yousaf, R., Rasul, A., Shah, G. M., Khalil, A. A. K., Wahab, A., Khan, H. Z., et al. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220628123224 · Cited by 13
Zhao, Y., Zhang, X., Chen, J., Lin, C., Shao, R., Yan, C., & Chen, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149730 · Cited by 12
GHRELIN AND ATHEROSCLEROSIS: HUMAN, EXPERIMENTAL ANIMAL AND CELL CULTURE STUDIES
Kellokoski, E. (2009) · doi:10.13140/rg.2.2.29210.29128 · Cited by 12
Metadata
- Authors
- Vestergaard, E. T., Gormsen, L. C., Jessen, N., Lund, S., Hansen, T. K., Moller, N., & Jorgensen, J. O. L.
- Affiliations
- Aarhus University Hospital (DK)
- From Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital, Aarhus, Denmark
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-12-01
- Volume
- 57
- Issue
- 12
- Pages
- 3205-3210
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2584125
- OpenAlex
- W2105363738
- Semantic Scholar
- 0a7d7a10a4e399792726c97d988cf2d1e44e6736
- Cited by
- 156
- References
- 28
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 9 · 2019: 5 · 2018: 4 · 2017: 11 · 2016: 7 · 2015: 8 · 2014: 18 · 2013: 15 · 2012: 14
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Aarhus Universitetshospital
- World Anti-Doping Agency
- Novo Nordisk
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- ghrelin, insulin resistance, lipolysis, growth hormone, growth hormone secretagogue receptor, skeletal muscle, AMPK, cortisol, substrate metabolism, energy crisis
- MeSH terms
- Adrenocorticotropic Hormone, Double-Blind Method, Humans, Hydrocortisone, Hypopituitarism, Infusions, Intravenous, Insulin Resistance, Lipolysis, Male, Middle Aged, Reference Values, Growth Hormone, Signal Transduction, Cross-Over Studies, Ghrelin, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.